Detalhe da pesquisa
1.
Contributions of Nrf2 to Puerarin Prevention of Cardiac Hypertrophy and its Metabolic Enzymes Expression in Rats.
J Pharmacol Exp Ther
; 366(3): 458-469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945930
2.
Puerarin Alleviates Lipopolysaccharide-Induced Myocardial Fibrosis by Inhibiting PARP-1 to Prevent HMGB1-Mediated TLR4-NF-κB Signaling Pathway.
Cardiovasc Toxicol
; 20(5): 482-491, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236896
3.
Effect of puerarin on action potential and sodium channel activation in human hypertrophic cardiomyocytes.
Biosci Rep
; 40(2)2020 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32003781
4.
Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats.
Front Pharmacol
; 9: 540, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29928229
5.
Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress.
Naunyn Schmiedebergs Arch Pharmacol
; 390(5): 535-545, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28210753
6.
Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis.
Stem Cells Int
; 2016: 1031794, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26783397
7.
Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Int J Cardiol
; 177(3): 764-70, 2014 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25465825
8.
Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy.
Braz J Med Biol Res
; 45(12): 1150-6, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23044624
9.
Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
Braz. j. med. biol. res
; 45(12): 1150-1156, Dec. 2012. ilus, tab
Artigo
em Inglês
| LILACS | ID: lil-659639